Abstract
Anti-glutamic acid decarboxylase (GAD) antibodies have been discovered in a variety of neurological syndromes with unique presentations. These syndromes include limbic encephalitis (LE), stiff person syndrome (SPS), opsoclonus-myoclonus-ataxia syndrome, cerebellar ataxia, status epilepticus, and palatal myoclonus among others. We present two patients who presented with Guillain-Barré (GBS) and myasthenia gravis (MG) like syndromes, who were found to have anti-GAD antibodies. These case reports highlight the complex presentation of patients with neurological disorders associated with anti-GAD antibodies. The proper identification of anti-GAD antibody's presence has proven to be beneficial in treatment and provide enhanced quality of life.
Cite
CITATION STYLE
Herard, K., Khanni, J. L., Alusma- Hibbert, K., Samuels, C. R., & Espinosa, P. S. (2019). Neurological Disorders Associated with Glutamic Acid Decarboxylase Antibodies. Cureus. https://doi.org/10.7759/cureus.4738
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.